0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Artificial Pancreas Devices Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-29D8786
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Artificial Pancreas Devices Systems Market Outlook 2022
BUY CHAPTERS

Artificial Pancreas Devices Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-29D8786
Report
August 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Pancreas Devices Systems- Market Size

The global market for Artificial Pancreas Devices Systems was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 246 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.

Artificial Pancreas Devices Systems- Market

Artificial Pancreas Devices Systems- Market

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Pancreas Devices Systems by region & country, by Type, and by Application.
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
Market Segmentation

Scope of Artificial Pancreas Devices Systems- Market Report

Report Metric Details
Report Name Artificial Pancreas Devices Systems- Market
Forecasted market size in 2031 US$ 246 million
CAGR 12.1%
Forecasted years 2025 - 2031
Segment by Type
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other Systems
Segment by Application
  • Hospitals
  • Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Artificial Pancreas Devices Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Artificial Pancreas Devices Systems- Market size in 2031?

Ans: The Artificial Pancreas Devices Systems- Market size in 2031 will be US$ 246 million.

What is the Medtronic share in Artificial Pancreas Devices Systems- Market?

Ans: Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.

What is the Artificial Pancreas Devices Systems- Market share by type?

Ans: In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%.

Who are the main players in the Artificial Pancreas Devices Systems- Market report?

Ans: The main players in the Artificial Pancreas Devices Systems- Market are Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed

What are the Application segmentation covered in the Artificial Pancreas Devices Systems- Market report?

Ans: The Applications covered in the Artificial Pancreas Devices Systems- Market report are Hospitals, Clinics

What are the Type segmentation covered in the Artificial Pancreas Devices Systems- Market report?

Ans: The Types covered in the Artificial Pancreas Devices Systems- Market report are Threshold Suspended Device Systems, Hybrid Closed-loop APDS, Other Systems

1 Market Overview
1.1 Artificial Pancreas Devices Systems Product Introduction
1.2 Global Artificial Pancreas Devices Systems Market Size Forecast
1.2.1 Global Artificial Pancreas Devices Systems Sales Value (2020-2031)
1.2.2 Global Artificial Pancreas Devices Systems Sales Volume (2020-2031)
1.2.3 Global Artificial Pancreas Devices Systems Sales Price (2020-2031)
1.3 Artificial Pancreas Devices Systems Market Trends & Drivers
1.3.1 Artificial Pancreas Devices Systems Industry Trends
1.3.2 Artificial Pancreas Devices Systems Market Drivers & Opportunity
1.3.3 Artificial Pancreas Devices Systems Market Challenges
1.3.4 Artificial Pancreas Devices Systems Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Pancreas Devices Systems Players Revenue Ranking (2024)
2.2 Global Artificial Pancreas Devices Systems Revenue by Company (2020-2025)
2.3 Global Artificial Pancreas Devices Systems Players Sales Volume Ranking (2024)
2.4 Global Artificial Pancreas Devices Systems Sales Volume by Company Players (2020-2025)
2.5 Global Artificial Pancreas Devices Systems Average Price by Company (2020-2025)
2.6 Key Manufacturers Artificial Pancreas Devices Systems Manufacturing Base and Headquarters
2.7 Key Manufacturers Artificial Pancreas Devices Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Artificial Pancreas Devices Systems
2.9 Artificial Pancreas Devices Systems Market Competitive Analysis
2.9.1 Artificial Pancreas Devices Systems Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Pancreas Devices Systems Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Pancreas Devices Systems as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Threshold Suspended Device Systems
3.1.2 Hybrid Closed-loop APDS
3.1.3 Other Systems
3.2 Global Artificial Pancreas Devices Systems Sales Value by Type
3.2.1 Global Artificial Pancreas Devices Systems Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Artificial Pancreas Devices Systems Sales Value, by Type (2020-2031)
3.2.3 Global Artificial Pancreas Devices Systems Sales Value, by Type (%) (2020-2031)
3.3 Global Artificial Pancreas Devices Systems Sales Volume by Type
3.3.1 Global Artificial Pancreas Devices Systems Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Artificial Pancreas Devices Systems Sales Volume, by Type (2020-2031)
3.3.3 Global Artificial Pancreas Devices Systems Sales Volume, by Type (%) (2020-2031)
3.4 Global Artificial Pancreas Devices Systems Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Artificial Pancreas Devices Systems Sales Value by Application
4.2.1 Global Artificial Pancreas Devices Systems Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Artificial Pancreas Devices Systems Sales Value, by Application (2020-2031)
4.2.3 Global Artificial Pancreas Devices Systems Sales Value, by Application (%) (2020-2031)
4.3 Global Artificial Pancreas Devices Systems Sales Volume by Application
4.3.1 Global Artificial Pancreas Devices Systems Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Artificial Pancreas Devices Systems Sales Volume, by Application (2020-2031)
4.3.3 Global Artificial Pancreas Devices Systems Sales Volume, by Application (%) (2020-2031)
4.4 Global Artificial Pancreas Devices Systems Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Artificial Pancreas Devices Systems Sales Value by Region
5.1.1 Global Artificial Pancreas Devices Systems Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Artificial Pancreas Devices Systems Sales Value by Region (2020-2025)
5.1.3 Global Artificial Pancreas Devices Systems Sales Value by Region (2026-2031)
5.1.4 Global Artificial Pancreas Devices Systems Sales Value by Region (%), (2020-2031)
5.2 Global Artificial Pancreas Devices Systems Sales Volume by Region
5.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Region (2020-2025)
5.2.3 Global Artificial Pancreas Devices Systems Sales Volume by Region (2026-2031)
5.2.4 Global Artificial Pancreas Devices Systems Sales Volume by Region (%), (2020-2031)
5.3 Global Artificial Pancreas Devices Systems Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Artificial Pancreas Devices Systems Sales Value, 2020-2031
5.4.2 North America Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Artificial Pancreas Devices Systems Sales Value, 2020-2031
5.5.2 Europe Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Artificial Pancreas Devices Systems Sales Value, 2020-2031
5.6.2 Asia Pacific Artificial Pancreas Devices Systems Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Artificial Pancreas Devices Systems Sales Value, 2020-2031
5.7.2 South America Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Value, 2020-2031
5.8.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value
6.2.1 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.2.2 Key Countries/Regions Artificial Pancreas Devices Systems Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.3.2 United States Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.4.2 Europe Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.5.2 China Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.5.3 China Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.6.2 Japan Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.7.2 South Korea Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.8.2 Southeast Asia Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Artificial Pancreas Devices Systems Sales Value, 2020-2031
6.9.2 India Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
6.9.3 India Artificial Pancreas Devices Systems Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medtronic Artificial Pancreas Devices Systems Product Offerings
7.1.5 Medtronic Recent Development
7.2 Bigfoot Biomedical
7.2.1 Bigfoot Biomedical Company Information
7.2.2 Bigfoot Biomedical Introduction and Business Overview
7.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Offerings
7.2.5 Bigfoot Biomedical Recent Development
7.3 Beta Bionics
7.3.1 Beta Bionics Company Information
7.3.2 Beta Bionics Introduction and Business Overview
7.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Offerings
7.3.5 Beta Bionics Recent Development
7.4 Admetsys
7.4.1 Admetsys Company Information
7.4.2 Admetsys Introduction and Business Overview
7.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Admetsys Artificial Pancreas Devices Systems Product Offerings
7.4.5 Admetsys Recent Development
7.5 Insulet
7.5.1 Insulet Company Information
7.5.2 Insulet Introduction and Business Overview
7.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Insulet Artificial Pancreas Devices Systems Product Offerings
7.5.5 Insulet Recent Development
7.6 Tandem Diabetes Care
7.6.1 Tandem Diabetes Care Company Information
7.6.2 Tandem Diabetes Care Introduction and Business Overview
7.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Offerings
7.6.5 Tandem Diabetes Care Recent Development
7.7 Defymed
7.7.1 Defymed Company Information
7.7.2 Defymed Introduction and Business Overview
7.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Defymed Artificial Pancreas Devices Systems Product Offerings
7.7.5 Defymed Recent Development
8 Industry Chain Analysis
8.1 Artificial Pancreas Devices Systems Industrial Chain
8.2 Artificial Pancreas Devices Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Pancreas Devices Systems Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Pancreas Devices Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Artificial Pancreas Devices Systems Market Trends
 Table 2. Artificial Pancreas Devices Systems Market Drivers & Opportunity
 Table 3. Artificial Pancreas Devices Systems Market Challenges
 Table 4. Artificial Pancreas Devices Systems Market Restraints
 Table 5. Global Artificial Pancreas Devices Systems Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Artificial Pancreas Devices Systems Revenue Market Share by Company (2020-2025)
 Table 7. Global Artificial Pancreas Devices Systems Sales Volume by Company (2020-2025) & (Units)
 Table 8. Global Artificial Pancreas Devices Systems Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Artificial Pancreas Devices Systems Price by Company (2020-2025) & (USD/Unit)
 Table 10. Key Manufacturers Artificial Pancreas Devices Systems Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Artificial Pancreas Devices Systems Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Artificial Pancreas Devices Systems
 Table 13. Global Artificial Pancreas Devices Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Pancreas Devices Systems as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Pancreas Devices Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Artificial Pancreas Devices Systems Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Artificial Pancreas Devices Systems Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Artificial Pancreas Devices Systems Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Artificial Pancreas Devices Systems Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Artificial Pancreas Devices Systems Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
 Table 22. Global Artificial Pancreas Devices Systems Sales Volume by Type (2020-2025) & (Units)
 Table 23. Global Artificial Pancreas Devices Systems Sales Volume by Type (2026-2031) & (Units)
 Table 24. Global Artificial Pancreas Devices Systems Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Artificial Pancreas Devices Systems Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Artificial Pancreas Devices Systems Price by Type (2020-2025) & (USD/Unit)
 Table 27. Global Artificial Pancreas Devices Systems Price by Type (2026-2031) & (USD/Unit)
 Table 28. Global Artificial Pancreas Devices Systems Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Artificial Pancreas Devices Systems Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Artificial Pancreas Devices Systems Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Artificial Pancreas Devices Systems Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Artificial Pancreas Devices Systems Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Artificial Pancreas Devices Systems Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
 Table 34. Global Artificial Pancreas Devices Systems Sales Volume by Application (2020-2025) & (Units)
 Table 35. Global Artificial Pancreas Devices Systems Sales Volume by Application (2026-2031) & (Units)
 Table 36. Global Artificial Pancreas Devices Systems Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Artificial Pancreas Devices Systems Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Artificial Pancreas Devices Systems Price by Application (2020-2025) & (USD/Unit)
 Table 39. Global Artificial Pancreas Devices Systems Price by Application (2026-2031) & (USD/Unit)
 Table 40. Global Artificial Pancreas Devices Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Artificial Pancreas Devices Systems Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Artificial Pancreas Devices Systems Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Artificial Pancreas Devices Systems Sales Value by Region (2020-2025) & (%)
 Table 44. Global Artificial Pancreas Devices Systems Sales Value by Region (2026-2031) & (%)
 Table 45. Global Artificial Pancreas Devices Systems Sales Volume by Region (Units): 2020 VS 2024 VS 2031
 Table 46. Global Artificial Pancreas Devices Systems Sales Volume by Region (2020-2025) & (Units)
 Table 47. Global Artificial Pancreas Devices Systems Sales Volume by Region (2026-2031) & (Units)
 Table 48. Global Artificial Pancreas Devices Systems Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Artificial Pancreas Devices Systems Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Artificial Pancreas Devices Systems Average Price by Region (2020-2025) & (USD/Unit)
 Table 51. Global Artificial Pancreas Devices Systems Average Price by Region (2026-2031) & (USD/Unit)
 Table 52. Key Countries/Regions Artificial Pancreas Devices Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Artificial Pancreas Devices Systems Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Artificial Pancreas Devices Systems Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Artificial Pancreas Devices Systems Sales Volume, (2020-2025) & (Units)
 Table 56. Key Countries/Regions Artificial Pancreas Devices Systems Sales Volume, (2026-2031) & (Units)
 Table 57. Medtronic Company Information
 Table 58. Medtronic Introduction and Business Overview
 Table 59. Medtronic Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 60. Medtronic Artificial Pancreas Devices Systems Product Offerings
 Table 61. Medtronic Recent Development
 Table 62. Bigfoot Biomedical Company Information
 Table 63. Bigfoot Biomedical Introduction and Business Overview
 Table 64. Bigfoot Biomedical Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 65. Bigfoot Biomedical Artificial Pancreas Devices Systems Product Offerings
 Table 66. Bigfoot Biomedical Recent Development
 Table 67. Beta Bionics Company Information
 Table 68. Beta Bionics Introduction and Business Overview
 Table 69. Beta Bionics Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 70. Beta Bionics Artificial Pancreas Devices Systems Product Offerings
 Table 71. Beta Bionics Recent Development
 Table 72. Admetsys Company Information
 Table 73. Admetsys Introduction and Business Overview
 Table 74. Admetsys Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 75. Admetsys Artificial Pancreas Devices Systems Product Offerings
 Table 76. Admetsys Recent Development
 Table 77. Insulet Company Information
 Table 78. Insulet Introduction and Business Overview
 Table 79. Insulet Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Insulet Artificial Pancreas Devices Systems Product Offerings
 Table 81. Insulet Recent Development
 Table 82. Tandem Diabetes Care Company Information
 Table 83. Tandem Diabetes Care Introduction and Business Overview
 Table 84. Tandem Diabetes Care Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 85. Tandem Diabetes Care Artificial Pancreas Devices Systems Product Offerings
 Table 86. Tandem Diabetes Care Recent Development
 Table 87. Defymed Company Information
 Table 88. Defymed Introduction and Business Overview
 Table 89. Defymed Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 90. Defymed Artificial Pancreas Devices Systems Product Offerings
 Table 91. Defymed Recent Development
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. Artificial Pancreas Devices Systems Downstream Customers
 Table 95. Artificial Pancreas Devices Systems Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Artificial Pancreas Devices Systems Product Picture
 Figure 2. Global Artificial Pancreas Devices Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Artificial Pancreas Devices Systems Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Artificial Pancreas Devices Systems Sales Volume (2020-2031) & (Units)
 Figure 5. Global Artificial Pancreas Devices Systems Sales Price (2020-2031) & (USD/Unit)
 Figure 6. Artificial Pancreas Devices Systems Report Years Considered
 Figure 7. Global Artificial Pancreas Devices Systems Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Artificial Pancreas Devices Systems Players Sales Volume Ranking (2024) & (Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Artificial Pancreas Devices Systems Revenue in 2024
 Figure 10. Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Threshold Suspended Device Systems Picture
 Figure 12. Hybrid Closed-loop APDS Picture
 Figure 13. Other Systems Picture
 Figure 14. Global Artificial Pancreas Devices Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Artificial Pancreas Devices Systems Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Artificial Pancreas Devices Systems Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
 Figure 17. Global Artificial Pancreas Devices Systems Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Artificial Pancreas Devices Systems Price by Type (2020-2031) & (USD/Unit)
 Figure 19. Product Picture of Hospitals
 Figure 20. Product Picture of Clinics
 Figure 21. Global Artificial Pancreas Devices Systems Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Artificial Pancreas Devices Systems Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Artificial Pancreas Devices Systems Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
 Figure 24. Global Artificial Pancreas Devices Systems Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Artificial Pancreas Devices Systems Price by Application (2020-2031) & (USD/Unit)
 Figure 26. North America Artificial Pancreas Devices Systems Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Artificial Pancreas Devices Systems Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Artificial Pancreas Devices Systems Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Artificial Pancreas Devices Systems Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Artificial Pancreas Devices Systems Sales Volume (%), (2020-2031)
 Figure 38. United States Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Artificial Pancreas Devices Systems Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Artificial Pancreas Devices Systems Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Artificial Pancreas Devices Systems Sales Value by Application (%), 2024 VS 2031
 Figure 59. Artificial Pancreas Devices Systems Industrial Chain
 Figure 60. Artificial Pancreas Devices Systems Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI